Member Info for gggg21

Well done holders and those newly invested. Some great posts at the weekend from genuine lot and educated investors - can see the sentiment returning to synairgen simmered all day then whoosh last 35mins so difficult to buy any volume constant NT and auction for over 5mins.

I said that dirty drop friday reminded me of 4th December. Well today reminded me of Monday 7th December almost identical again...went on to do a 100% rise - expect the same from these levels.

Bring on the expected updates. Synairgen is starting to get more exposure. The potential of synairgen as therapeutic is clear. Value will come. Polar added 5m after all.

I am with IG and was NT and then auction for 5 mins, 8.57% up at time of writing been large block buyer today

In auction here we go, remember this last time

NT online to buy, they keep playing with spread, they want your shares

I have bombarded journos and the like on sng today, han**** speaking at 5pm, tighter restrictions coming - it worked with novacyt getting attention. Seems like a big PR push by the company to. Perfect time to announce phase 3 trials.

Hat Chris you’ll do well at these prices. Seen a good for novacyt faces here who smashed it and will continue to smash it. I wonder if a major pharma May want early access/to partner with us so they get first dibs....just thinking out loud. With 79% success rate the odds of success is good

Nolupus good job it’s ended up all over the internet eh and will be brought up by the media now in France and raised then.

Indeed well it’s already got a fair bit of attention anyway as I have quite a lot of french followers as (novacyt is dual listed) and they have dm me about synairgen. Night

Was sharedycat on twitter. He just shared it. What do the trolls have to say about this. Mentioned alongside lilly. Clearly synairgen is standing out in this “crowded market” ;) Now the french will be looking into synairgen too. Worldwide attention coming.

From twitter from a very knowledgeable poster hope they don’t mind me sharing. This is from senior french minster to the french pm requesting treatments, synairgen mentioned by name as one of 16 to be made available this is from a letter Friday https://www.upr.fr/actualite/lettre-commune-de-nicolas-dupont-aignan-francois-asselineau-et-florian-philippot-a-olivier-veran-sur-la-situation-sanitaire/
Remember french vaccine roll out basically no existential slow and french always against vaccine. Looks like synairgen is really getting noticed. First us fda and now french senior minister

Thanks runfox for that. I didn’t realise it was actually that high. RM was right the results were outstanding. I did a little review of p3 to approval success rate and it’s actually 75.3% (covid very unique times so dare I say the odds even more increased) hoping no rns tomorrow morning so I can add some more. Probably should say thankyou to some of the trolls as they have made me read/research more and made me even more confident.

From professor horby today. Hence why therapeutics and testing will always be needed. Simples.
He says every virus mutates to create different strains but vaccines are updated to keep up with them.

"When there's a lot of immunity in the population, whether that's a vaccine or natural, we will see viruses emerge that escape that immunity.

"In the longer term, that will happen and we we will have to update that vaccine.

"But we do that every year with influenza so I don't think that's going to be a problem in the short term."

He says scientists do not yet know how long immunity lasts and therefore how often the population will need to be re-vaccinated.

He says: "The one virus we've managed to get rid of, smallpox, had very different characteristics to this virus... this one will not go away.

"I think we are going to have to live with it... it may well become more of an endemic.

Anyone else think there will be some big publicity and media in the states upon start of phase 3 trial in the US. Could get a lot of interest then globally

Sanotize*

Sanitizer is actually well behind it is not starting entering its final phase. It is phase 2 trial still. Sng about to start phase 3, already been in U.K. for a while and tested in U.K. hospitals and home. Hence ahead.

Just wait it’s coming not to much longer to wait actually. I feel like the core nova holders are very knowledgeable now and have a good idea what is coming.
I tweeted today about other diagnostic companies share price rise continuing up again, mcap and pe. Nova time is coming. Will revisit end of the month.

Indeed i am most excited about the lamp test update as you know these lamp tests will be able to run on the q machine - this is why imo the manufacturing capacity of the q machine has been increased so much. Graham will have some nice news to release over the coming weeks i am sure, maybe even a new quickest pcr test to :)

Porky. I just know this. Show me another therapeutic with such great potential that could be used for COVID, copd (it’s initial purpose) and future respiratory diseases. How can you put a price on this? No wonder the fda have fast tracked this and took over phase 3 trial in a way. I don’t know what I’m more excited about this or nova which I continue to hold

The odds of developing severe disease (e.g. requiring ventilation or resulting in death) during the treatment period (day 1 to day 16) were significantly reduced by 79% for patients receiving SNG001 compared to patients who received placebo (OR 0.21 [95% CI 0.04-0.97]; p=0.046).



Patients who received SNG001 were more than twice as likely to recover (defined as 'no limitation of activities' or 'no clinical or virological evidence of infection') over the course of the treatment period compared to those receiving placebo (HR 2.19 [95% CI 1.03-4.69]; p=0.043)

....that's why i said about economies of scale and would end up (so yes not currently and ok maybe twice as much or something) - was just trying to say it won't end up 3k that is all. If we want to start being pedantic we can look at the cost of an asthma inhaler over a life time lol

Put the value on a life, hospital admission, long covid treatment.

Price would significantly reduce with economies of scale/mass production. The actual cost of the treatment is not "3k" from my understanding. The reason it is seen as 3k is the man hours required currently apportioned against each individual person participating. The end price would end up the same as say the asthma inhaler and other inhalers in the end. Happy to be corrected.